Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.

Lykens NM, Coughlin DJ, Reddi JM, Lutz GJ, Tallent MK.

PLoS One. 2017 Feb 8;12(2):e0171538. doi: 10.1371/journal.pone.0171538. eCollection 2017.

2.

Somatostatin signaling in neuronal cilia is critical for object recognition memory.

Einstein EB, Patterson CA, Hon BJ, Regan KA, Reddi J, Melnikoff DE, Mateer MJ, Schulz S, Johnson BN, Tallent MK.

J Neurosci. 2010 Mar 24;30(12):4306-14. doi: 10.1523/JNEUROSCI.5295-09.2010.

3.

Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.

Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ.

J Neurosci. 2009 Jun 17;29(24):7633-8. doi: 10.1523/JNEUROSCI.0950-09.2009.

4.

In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.

Tallent MK, Varghis N, Skorobogatko Y, Hernandez-Cuebas L, Whelan K, Vocadlo DJ, Vosseller K.

J Biol Chem. 2009 Jan 2;284(1):174-81. doi: 10.1074/jbc.M807431200. Epub 2008 Nov 11.

5.

Somatostatin receptor subtype 4 couples to the M-current to regulate seizures.

Qiu C, Zeyda T, Johnson B, Hochgeschwender U, de Lecea L, Tallent MK.

J Neurosci. 2008 Apr 2;28(14):3567-76. doi: 10.1523/JNEUROSCI.4679-07.2008.

6.

Somatostatin: an endogenous antiepileptic.

Tallent MK, Qiu C.

Mol Cell Endocrinol. 2008 May 14;286(1-2):96-103. doi: 10.1016/j.mce.2007.12.004. Epub 2007 Dec 14. Review.

7.

Somatostatin in the dentate gyrus.

Tallent MK.

Prog Brain Res. 2007;163:265-84. Review.

PMID:
17765724
8.

K+ M-current regulates the transition to seizures in immature and adult hippocampus.

Qiu C, Johnson BN, Tallent MK.

Epilepsia. 2007 Nov;48(11):2047-58. Epub 2007 Jul 25.

9.

Presynaptic inhibition of glutamate release by neuropeptides: use-dependent synaptic modification.

Tallent MK.

Results Probl Cell Differ. 2008;44:177-200. Review.

PMID:
17554500
10.

Cortistatin overexpression in transgenic mice produces deficits in synaptic plasticity and learning.

Tallent MK, Fabre V, Qiu C, Calbet M, Lamp T, Baratta MV, Suzuki C, Levy CL, Siggins GR, Henriksen SJ, Criado JR, Roberts A, de Lecea L.

Mol Cell Neurosci. 2005 Nov;30(3):465-75. Epub 2005 Sep 22.

PMID:
16182561
11.

Interneuron Diversity series: Interneuronal neuropeptides--endogenous regulators of neuronal excitability.

Baraban SC, Tallent MK.

Trends Neurosci. 2004 Mar;27(3):135-42. Review.

PMID:
15036878
12.

Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons.

Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2053-8. Epub 2003 Feb 3.

13.

Somatostatin depresses long-term potentiation and Ca2+ signaling in mouse dentate gyrus.

Baratta MV, Lamp T, Tallent MK.

J Neurophysiol. 2002 Dec;88(6):3078-86.

14.

Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Tallent MK, Madamba SG, Siggins GR.

J Neurosci. 2001 Sep 1;21(17):6940-8.

15.

A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus.

Sanna PP, Berton F, Cammalleri M, Tallent MK, Siggins GR, Bloom FE, Francesconi W.

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8653-7.

16.

Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity.

Tallent MK, Siggins GR.

J Neurophysiol. 1999 Apr;81(4):1626-35.

17.
18.

Supplemental Content

Loading ...
Support Center